Alpha Cognition Inc
ACOG
Hisse Senetlerindeki Sıralama
#20056
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Hisse Fiyatı
$8.63
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$134.04M
Değişim (1 gün)
0.23%
Değişim (1 yıl)
71.57%
Ülke
US
Ticaret Alpha Cognition Inc (ACOG)
Kategori
Healthcare
Alpha Cognition Inc (ACOG) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $5.46 - 2024-12-01
Gün sonu en düşük fiyat: $18.75 - 2021-06-01
Gün sonu en düşük fiyat: $18.75 - 2021-06-01
Alpha Cognition Inc için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2024 | -51.49% |
| 2023 | 87.35% |
| 2022 | -73.46% |
| 2021 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.29 | -4.16% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
